← All trials
NCT00089362
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2004
- Primary completion
- Jan 1, 2008
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- National Cancer Institute (NCI)Lead sponsor
- Cornell UniversityOverall official - principal investigator
Drugs studied
Indications studied
- Squamous Cell Carcinoma of Head and Neck
- Breast Neoplasms
- Basal Cell Carcinoma
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Colonic Neoplasms
- Carcinoma, Adenoid Cystic
- Graft vs Host Disease
- Granuloma
- Melanoma
- Nasopharyngeal Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Neuroblastoma
- Oropharyngeal Neoplasms
- Ovarian Neoplasms
- Salivary Gland Neoplasms
- Stomach Neoplasms
- Carcinoma, Mucoepidermoid
- Carcinoma, Verrucous
- Papilloma, Inverted
- Breast Neoplasms, Male
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.